Article ; Online: The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis.
Taiwanese journal of obstetrics & gynecology
2021 Volume 60, Issue 1, Page(s) 1–8
Abstract: To assess the roles of the low molecular weight heparin (LMWH) on recurrent pregnancy loss (RPL). The relevant studies of all randomized controlled trials (RCTs) were retrieved, and the systematic evaluation was conducted. PubMed, Embase, and Cochrane ... ...
| Abstract | To assess the roles of the low molecular weight heparin (LMWH) on recurrent pregnancy loss (RPL). The relevant studies of all randomized controlled trials (RCTs) were retrieved, and the systematic evaluation was conducted. PubMed, Embase, and Cochrane library databases were searched by using keywords, including low-molecular-weight heparin or LMWH, and recurrent miscarriage or recurrent pregnancy loss in pregnant women from their earliest data to February 2020. Two investigators independently evaluated eligibility. Risk ratios (RRs) and their corresponding 95% confidence interval (CI) were determined. To pool the results, this meta-analysis was performed using random-effect model due to the high heterogeneity among these eight studies. A total of eight RCTs involving 1854 participants were included in the meta-analysis involving 963 patients with RPL who were prescribed LMWH (enoxaparin, tinzaparin, or dalteparin) alone and 891 patients who were treated with no LMWH interventions (placebo, folic acid or non-treatment) were compared. Pooled data from the remaining eight RCTs showed the differences between intervention groups and control groups. Compared with control groups, LMWH had significantly improved live births (RR,1.19; 95%CI, 1.03 to 1.38; P = 0.02), and reduced miscarriage rates (RR, 0.62; 95%CI, 0.43 to 0.91; P = 0.01). The study suggested that LMWH could improve the live births and reduce the miscarriage rates of RPL. Therefore, LMWH might be a good treatment choice for women with unexplained PRL. |
|---|---|
| MeSH term(s) | Abortion, Habitual/drug therapy ; Adult ; Cardiovascular Agents/therapeutic use ; Female ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Live Birth ; Pregnancy ; Randomized Controlled Trials as Topic ; Treatment Outcome |
| Chemical Substances | Cardiovascular Agents ; Heparin, Low-Molecular-Weight |
| Language | English |
| Publishing date | 2021-01-25 |
| Publishing country | China (Republic : 1949- ) |
| Document type | Journal Article ; Meta-Analysis ; Systematic Review |
| ZDB-ID | 2202946-1 |
| ISSN | 1875-6263 ; 1028-4559 |
| ISSN (online) | 1875-6263 |
| ISSN | 1028-4559 |
| DOI | 10.1016/j.tjog.2020.11.001 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.